eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Determination That OPANA ER (Oxymorphone Hydrochloride) Drug Products Covered by New Drug Application 21-610 Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

Determination That OPANA ER (Oxymorphone Hydrochloride) Drug Products Covered by New Drug Application 21-610 Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

Document ID: FDA-2012-P-0895-0015
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-15099
View Document:  View as format pdf View as format html

Details Information

Document Subtype: General Notice
Received Date: June 25 2013, at 12:00 AM Eastern Daylight Time
Start-End Page: 38053 - 38053
Page Count: 1
Comment Start Date: June 25 2013, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.